Company profile for Life Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Life Biosciences is dedicated to developing novel therapies to extend healthy human lifespan by targeting the biological causes of aging. Founded in 2017 and headquartered in Boston, MA, we are pursuing therapies targeting three molecular pathways that regulate the biology of aging: mitochondrial uncoupling, chaperone-mediated autophagy, and epigenetic reprogramming. Our platform approach enables us to develop medicines with t...
Life Biosciences is dedicated to developing novel therapies to extend healthy human lifespan by targeting the biological causes of aging. Founded in 2017 and headquartered in Boston, MA, we are pursuing therapies targeting three molecular pathways that regulate the biology of aging: mitochondrial uncoupling, chaperone-mediated autophagy, and epigenetic reprogramming. Our platform approach enables us to develop medicines with the potential to prevent, treat, and/or reverse multiple aging-related diseases, each with critical unmet needs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
75 Park Plaza Level Three Boston, MA 02116
Telephone
Telephone
(857) 400-9245
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/03/3179183/0/en/Life-Biosciences-Appoints-Industry-Veteran-David-Guyer-M-D-to-Board-of-Directors.html

GLOBENEWSWIRE
03 Nov 2025

https://www.globenewswire.com/news-release/2025/08/26/3139053/0/en/Life-Biosciences-Presents-New-Data-at-ARDD-2025-on-the-Company-s-Partial-Epigenetic-Reprogramming-Platform-in-Liver-and-Ocular-Diseases.html

GLOBENEWSWIRE
26 Aug 2025

https://www.globenewswire.com/news-release/2025/07/22/3119160/0/en/Life-Biosciences-Announces-Research-Collaboration-with-SingHealth-Duke-NUS-Regenerative-Medicine-Institute-of-Singapore-REMEDIS-to-Expand-Pipeline-of-Cellular-Rejuvenation-Therapie.html

GLOBENEWSWIRE
22 Jul 2025

https://www.globenewswire.com/news-release/2025/01/27/3015524/0/en/Life-Biosciences-Appoints-Dr-Michael-Ringel-as-Chief-Operating-Officer.html

GLOBENEWSWIRE
27 Jan 2025

https://www.globenewswire.com/news-release/2024/10/21/2966155/0/en/Life-Biosciences-Presents-at-AAO-Highlighting-Progress-of-Nonhuman-Primate-Studies-Evaluating-Partial-Epigenetic-Reprogramming-to-Restore-Visual-Function.html

GLOBENEWSWIRE
21 Oct 2024

https://www.globenewswire.com/news-release/2023/05/23/2674227/0/en/Life-Biosciences-Expands-Team-with-the-Appointment-of-Ming-Yang-Ph-D-as-SVP-of-Research-and-Development.html

GLOBENEWSWIRE
23 May 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty